Cite
HARVARD Citation
Chevli, N. et al. (2022). 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy. Radiotherapy and oncology. pp. 37-43. [Online].